Dexamethasone versus Fentanyl as Adjuvants to Intrathecal Bupivacaine Anesthesia in Cesarean Section: Impacts on Analgesia Duration and Postoperative Outcomes
Open Access
- 1 October 2025
- journal article
- Published by Al-Rafidain University College in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
- Vol. 9 (2) , 16-21
Abstract
Background: Effective postoperative analgesia after cesarean section is essential to facilitate early maternal recovery and reduce opioid-related side effects. Although fentanyl is commonly used as an intrathecal adjuvant to bupivacaine, concerns about adverse effects such as pruritus and nausea have prompted exploration of alternatives like dexamethasone. Objective: To compare the efficacy and safety of intrathecal dexamethasone versus fentanyl as adjuvants to 0.5% bupivacaine in spinal anesthesia for cesarean section. Methods: In this quasi-randomized clinical study, 70 women undergoing elective cesarean section were allocated to receive spinal anesthesia with bupivacaine plus either fentanyl (10–25µg; Group F) or dexamethasone (2–4mg; Group D). Hemodynamic parameters, duration of postoperative analgesia, incidence of side effects, ambulation time, and patient satisfaction were assessed using validated instruments. Results: Group D demonstrated significantly longer analgesia duration (median 5.0 h [IQR 4.0–6.0]) compared to Group F (3.0 h [IQR 2.0–4.0], p<0.001). Post-spinal systolic blood pressure and heart rate were significantly higher in the dexamethasone group but remained within physiological limits. Adverse events such as pruritus and postoperative nausea/vomiting were significantly more frequent in Group F, while back pain was reported only in Group D (20%, p=0.011). Patient satisfaction was higher in group F (p<0.001), potentially due to earlier ambulation. Conclusions: Intrathecal dexamethasone is a safe and effective adjuvant to bupivacaine in cesarean section spinal anesthesia, offering prolonged analgesia and fewer opioid-related side effects compared to fentanyl. Further randomized trials with longer follow-up and neonatal outcomes are warranted.Keywords
This publication has 19 references indexed in Scilit:
- Intravenous Dexamethasone versus intrathecal Dexamethasone in Prolonging the Duration of Spinal Anesthesia and Postoperative Analgesia in Elective Cesarean SectionQJM: An International Journal of Medicine, 2024
- Perioperative patient satisfaction and its predictors following surgery and anesthesia services in North Shewa, Ethiopia. A multicenter prospective cross-sectional studyAnnals of Medicine & Surgery, 2022
- Local anaesthetic adjuncts for peripheral regional anaesthesia: a narrative reviewAnaesthesia, 2021
- Efficacy of Intrathecal Fentanyl for Cesarean Delivery: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential AnalysisAnesthesia & Analgesia, 2020
- Comparison of the efficacy of bupivacaine versus bupivacaine plus dexamethasone during surgical TAP block for post operative analgesia after caesarean sectionIndian Journal of Obstetrics and Gynecology Research, 2019
- Fentanyl: Receptor pharmacology, abuse potential, and implications for treatmentNeuroscience & Biobehavioral Reviews, 2019
- A Randomised Controlled Trial to Evaluate the Effectiveness of Intrathecal Bupivacaine Combined with Different Adjuvants (Fentanyl, Clonidine and Dexmedetomidine) in Caesarean SectionDrug Research, 2014
- Efficacy of epidural dexamethasone versus fentanyl on postoperative analgesiaJournal of Anesthesia, 2010
- Post cesarean delivery pain management: multimodal approachInternational Journal of Obstetric Anesthesia, 2006
- PATIENT-CONTROLLED EXTRADURAL ANALGESIA TO COMPARE BUPIVACAINE, FENTANYL AND BUPIVACAINE WITH FENTANYL IN THE TREATMENT OF POSTOPERATIVE PAINBritish Journal of Anaesthesia, 1993